Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:
Schedule
Product: | Dovato 50/300 |
Active Ingredients: | Dolutegravir sodium 52.6mg equivalent to dolutegravir 50mg Lamivudine 300mg |
Dosage Form: | Film coated tablet |
New Zealand Sponsor: | GlaxoSmithKline NZ Limited |
Manufacturer: | GlaxoSmithKline LLC, North Carolina, United States of America |
Product: | Sunitinib |
Active Ingredient: | Sunitinib 12.5mg |
Dosage Form: | Capsule |
New Zealand Sponsor: | Teva Pharma (New Zealand) Limited |
Manufacturer: | Teva Pharmaceutical Industries Limited, Kfar Saba, Israel |
Product: | Sunitinib |
Active Ingredient: | Sunitinib 25mg |
Dosage Form: | Capsule |
New Zealand Sponsor: | Teva Pharma (New Zealand) Limited |
Manufacturer: | Teva Pharmaceutical Industries Limited, Kfar Saba, Israel |
Product: | Sunitinib |
Active Ingredient: | Sunitinib 37.5mg |
Dosage Form: | Capsule |
New Zealand Sponsor: | Teva Pharma (New Zealand) Limited |
Manufacturer: | Teva Pharmaceutical Industries Limited, Kfar Saba, Israel |
Product: | Sunitinib |
Active Ingredient: | Sunitinib 50mg |
Dosage Form: | Capsule |
New Zealand Sponsor: | Teva Pharma (New Zealand) Limited |
Manufacturer: | Teva Pharmaceutical Industries Limited, Kfar Saba, Israel |
Product: | Teriflunomide Dr.Reddy’s |
Active Ingredient: | Teriflunomide 14mg |
Dosage Form: | Tablet |
New Zealand Sponsor: | Dr Reddy’s New Zealand Limited |
Manufacturer: | MSN Laboratories Private Limited, Nandigama, India |
Dated this 15th day of November 2021.
CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).